Posted by Michael Wonder on 14 Dec 2024
First treatment for peripheral thyrotoxicosis in patients with Allan-Herndon-Dudley syndrome
13 December 2024 - Emcitate can be used in patients of all ages.
The EMA has recommended granting a marketing authorisation in the European Union for Emcitate (tiratricol), an oral treatment for peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 deficiency.
